FindTrial
Sign In

Prediction model for pneumocystis jirovecii pneumonia in chronic kidney disease: a retrospective study

Prediction model for pneumocystis jirovecii pneumonia in chronic kidney disease: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109734
Enrollment
Unknown
Registered
2025-09-24
Start date
2022-04-01
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pneumocystis jirovecii pneumonia

Interventions

Observation group:None

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with chronic kidney disease; 2. Age over 18 years old; 3. Undergo Pneumocystis carinii nucleic acid test (BALF or sputum sample) and lung CT examination;

Exclusion criteria

Exclusion criteria: 1. Patients with other chronic lung diseases before the diagnosis of Pneumocystis carinii pneumonia; 2. Patients with heart failure pulmonary edema; 3. Patients with HIV infection, current cancer or solid organ transplantation;

Design outcomes

Primary

MeasureTime frame
To evaluate the effectiveness of pneumocystis carinii pneumonia risk in patients with chronic kidney disease;—

Countries

China

Contacts

Public ContactGang Xu

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

xugang@tjh.tjmu.edu.cn+86 135 0718 1312

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026